RB1 and breast cancer: Moreover, when cells from tumorspheres were challenged to a clonogenic assay, those derived from the YB cell line had a significantly higher clonogenic capacity than cells derived from the YA cell line, and similar to the parental one, further supporting the role of PRB in breast cancer malignancy (Figure 6).